Michele Baccarani
0000-0003-1999-1687
Publication & Citation Trends
Most Cited Works
Publications
1,433 total
Ponatinib efficacy and safety in Philadelphia chromosome–positive leukemia: final 5-year results of the phase 2 PACE trial PDF
Cited by 579
OpenAlex
Treatment-free remission in chronic myeloid leukemia: floating between expectation and evidence
Cited by 10
Semantic Scholar
Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial PDF
Cited by 937
OpenAlex
In chronic myeloid leukemia patients on second-line tyrosine kinase inhibitor therapy, deep sequencing of BCR-ABL1 at the time of warning may allow sensitive detection of emerging drug-resistant mutants OA
Cited by 11
Semantic Scholar
Clinical impact of low-burden BCR-ABL1 mutations detectable by amplicon deep sequencing in Philadelphia-positive acute lymphoblastic leukemia patients
Cited by 17
Semantic Scholar
Differences among young adults, adults and elderly chronic myeloid leukemia patients. OA
Cited by 93
Semantic Scholar
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib
Cited by 84
Semantic Scholar
Research Topics
Chronic Myeloid Leukemia Treatments
(759)
Chronic Lymphocytic Leukemia Research
(674)
Acute Lymphoblastic Leukemia research
(303)
Eosinophilic Disorders and Syndromes
(239)
Acute Myeloid Leukemia Research
(218)
Frequent Co-Authors
Affiliations
University of Siena
University of Bergamo
Goethe University Frankfurt
Leiden University
University of Copenhagen